Amphastar Pharmaceuticals (AMPH) Interest Expenses (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Interest Expenses of $7.3 million for Q1 2026, down 3.79% year-over-year from $7.6 million in Q1 2025, and up 10.03% quarter-over-quarter from $6.6 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Interest Expenses (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Interest Expenses history runs 14 years deep, the most recent figure standing at $7.3 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 3.79% year-over-year to $7.3 million; the TTM figure through Mar 2026 stood at $24.4 million (down 30.25% YoY), while the FY2025 annual figure was $407.9 million, up 328.13% from the prior year.
- Interest Expenses for Q1 2026 stood at $7.3 million, up from $6.6 million in the prior quarter.
- The five-year high for Interest Expenses was $482.0 million in Q2 2023, with the low at $600000.0 in Q1 2022.
- The 5-year median for Interest Expenses is $15.9 million (2023), against an average of $93.4 million.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses jumped 593.33% in 2024, then slumped 83.35% in 2025.
- Amphastar Pharmaceuticals' Interest Expenses stood at $3.9 million in 2022, then surged by 309.52% to $15.9 million in 2023, then tumbled by 81.77% to $2.9 million in 2024, then jumped by 129.17% to $6.6 million in 2025, then climbed by 10.03% to $7.3 million in 2026.
- Business Quant data shows AMPH's Interest Expenses at $7.3 million in Q1 2026, $6.6 million in Q4 2025, and $33.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 931.14 Mn | 641.02 Mn | 93.47 Mn | 6.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.33 Mn |
| Jun 30, 2026 | 11.33 Mn |
| Mar 31, 2026 | 7.30 Mn |
| Mar 31, 2026 | 7.30 Mn |
| Dec 31, 2025 | 6.63 Mn |
| Dec 31, 2025 | 6.63 Mn |
| Sep 30, 2025 | 33.33 Mn |
| Sep 30, 2025 | 33.33 Mn |
| Jun 30, 2025 | 20.00 Mn |
| Jun 30, 2025 | 20.00 Mn |
| Mar 31, 2025 | 7.58 Mn |
| Mar 31, 2025 | 7.58 Mn |
| Dec 31, 2024 | 2.89 Mn |
| Dec 31, 2024 | 2.89 Mn |
| Sep 30, 2024 | 168.76 Mn |
| Sep 30, 2024 | 168.76 Mn |
| Jun 30, 2024 | 120.12 Mn |
| Jun 30, 2024 | 120.12 Mn |
| Mar 31, 2024 | 8.63 Mn |
| Mar 31, 2024 | 8.63 Mn |